4//SEC Filing
Doyle Janeen Noel 4
Accession 0001415889-25-015684
CIK 0001817713other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:00 PM ET
Size
7.3 KB
Accession
0001415889-25-015684
Insider Transaction Report
Form 4
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Transactions
- Award
Stock option (right to buy)
2025-06-02+154,000→ 154,000 totalExercise: $25.01Exp: 2035-06-01→ Common Stock (154,000 underlying) - Award
Common Stock
2025-06-02+44,000→ 44,000 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on June 1, 2026.
- [F2]25% of the shares subject to the option vest on May 14, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0002069239
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:00 PM ET
- Size
- 7.3 KB